Biotechnologie – field of the future

Next to the technical revolution of the steam engine in the 19th century and the development of chemistry and semi- conductor electronics in the 20th century bio- and gene-technology are key technologies of the 21st century besides information and telecommunication technology (IT).

Today biotechnology is already producing a dynamically growing market in all areas. Worldwide over 9,600 companies are already turning more than 280 billion € in this sector. (Global Biotech Report - Ibis World Dec. 2017) Particularly in the medical field biotechnology has become essential for example in the fight against cancer and infectious diseases. Currently there are 249 gene technology produced medicines licenced for use in German pharmacies.

  • Insulines for diabetics
  • Vaccines for hepatitis B or influenza
  • Means of dissolve blood clots in heart attack
  • Monoclonal antibodies for cancer treatment
  • Beta-Interferons for multiple sclerosis
  • TNFα inhibits for the treatment of rheumatoid arthritis
  • Coagulation for the treatment of haemophilia


these are only some examples of medicines and procedures already successfully produced using gene technology.

Furthermore the manufacture of improved foodstuffs, high quality chemicals, enzymes, washing and cleaning products will make life easier in the future and in particular play an increasing role in research projects with respect to the manufacture of biosynthetic materials and also in the efficient production of energy from sustainable raw materials.